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Abstract 
Purpose: To investigate the effect of Scrophularia ningpoensis extract (SNE) on streptozotocin-induced 
diabetic rats. 
Methods: SNE was obtained by steeping the dried Scrophularia ningpoensis in water at 60 oC three 
times, each for 1 h, before first drying in an oven at 100 oC and then freeze-drying the last extract thus 
obtained. Diabetic rats were prepared by a single intraperitoneal injection of a freshly prepared solution 
of streptozotocin (50 mg/kg). The rats were randomly divided into 6 groups of ten rats each: negative 
control group, control group, reference group (glibenclamide1 mg/kgbody weight) as well as SNE 
groups, (50, 100 and 200 mg/kg). Blood glucose and plasma insulin levels were evaluated in order to 
determine antihyperglycemic effect. Oxidative stress was evaluated in liver and kidney by antioxidant 
markers, viz, lipid peroxidation (LPO), superoxide dismutase (SOD), reduced glutathione (GSH), 
glutathione peroxidase (GPx) and catalase (CAT); blood serum levels of creatinine and urea were 
determined in both diabetic control and treated rats. 
Results: Compared with diabetic rats, oral administration of SNE at a concentration of 200 mg/kg daily 
for 30 days showed a significant decrease in fasting blood glucose to 120.21 ± 3.37 mg/dL (p < 0.05) 
and increased insulin level to 13.31 ± 0.67 uU/mL (p < 0.05). Furthermore, it significantly reduced 
biochemical parameters (serum creatinine, 0.86 ± 0.24 mg/dL, p < 0.05) and serum urea (41.86 ± 1.59 
mg/dL, p < 0.05).  
Conclusion: The results suggest that SNE may effectively normalize impaired antioxidant status in 
streptozotocin-induced diabetes in a dose-dependent manner. SNE has a protective effect against lipid 
peroxidation by scavenging free radicals and is thus capable of reducing the risk of diabetic 
complications. 
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Diabetes mellitus is a metabolic disease that 
manifests due to insulin insufficiency and/or 
insulin resistance and has become a serious 
health problem worldwide. In 2010, 
approximately 285 million adults between 20 and 
79 years of age in the world were affected by 
diabetes and it is expected that 439 million adults 
will have diabetes by 2030. The primary goals for 
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the management of diabetes include the tight 
regulation of glucose levels in the blood and the 
prevention of diabetic complications [1]. 
Hyperglycemic control is crucial for the 
prevention and delay of the progression of 
diabetic complications. 
 
Though diabetes is a non-communicable 
disease, it is considered to be one of the five 
leading causes of death in the world [2]. The 
disease is a complex metabolic disorder of the 
endocrine system. It is characterized by high 
blood glucose levels (hyperglycemia) due to the 
inability of the body cells to utilize glucose 
properly [3]. The increased blood glucose levels 
in diabetes produce superoxide anions, which 
generate hydroxyl radicals via Haber–Weiss 
reaction, resulting in peroxidation of membrane 
lipids and protein glycation. This leads to 
oxidative damage of cell membranes. These 
radicals further damage other important 
biomolecules including carbohydrates, proteins 
and deoxyribonucleic acid (DNA) [4-7]. 
 
Medicinal plants are widely used by the people of 
developing countries as alternative therapy. In 
China, hundreds of plants are used traditionally 
for the management of diabetes. Unfortunately, 
only a few of such Chinese medicinal plants have 
received scientific scrutiny. Despite the long 
traditional use of Scrophularia ningpoensis In 
diabetes [8,9], no systematic pharmacological 
work has been carried out on this plant. The 
present study was therefore designed to study 
the hypoglycemic effect of Scrophularia 
ningpoensis extract against streptozotocin 




Plant material and extraction 
 
Samples of Scrophularia ningpoensis were 
collected from Liuzhou City, Guangxi Province in 
China in March 2016. Taxonomic identification of 
the plant was performed by Professor Zhi Liu of 
Shandong University in China. A voucher 
specimen (no. SNE 20160308) was deposited in 
the herbarium of College of Pharmacy, 
Shandong University, China for future reference. 
 
The whole plant of Scrophularia ningpoensis was 
dried in an oven at 100 oC for 12 h. SNE was 
obtained by steeping the dried Scrophularia 
ningpoensis in water at 60 oC for three times. 
The procedure was repeated for 1 h each. The 
final extract was obtained after it had been dried 
in the oven. One gram powder was obtained 




SPF male Wistar rats, weighing 200 - 220 g, 
were provided by the Experimental Animal 
Center of Shandong Province (certificate no. 
SYXK2005 - 0002). The animals had free access 
to food and water, and were allowed to 
acclimatize for at least one week before use. The 
rat experiment was approved by the Animal Care 
and Use Committee of Shandong University 
(approval ref no. 20101004) and was carried out 
in compliance with Directive 2010/63/EU on the 





The rats were randomly divided into 6 groups of 
ten rats each: negative control group, model 
group, reference group (glibenclamide 1 mg/kg 
body weight) as well as SNE groups, namely, 50, 
100 and 200 mg/kg body weight. Treatments (in 
aqueous solution) were given orally once daily 
for 30 days.  
 
Preparation of experimental diabetes 
 
The animals were fasted overnight and diabetes 
was induced by a single intraperitoneal injection 
of a freshly prepared solution of streptozotocin 
(50 mg/kg) in citrate buffer (pH 4.5) [11,12]. After 
three days of STZ-injection, the rats were fasted 
for 6 h and blood was withdrawn by retroorbital 
puncture under ether anesthesia. Rats with 
moderate diabetes having hyperglycemia (that is, 
with blood glucose of 250–400 mg/dL) were used 




Rats were fasted overnight and the blood was 
withdrawn by retro orbital puncture under light 
ether anesthesia on the 1st, 15nd and 30th day 
post induction to determine blood glucose and 
plasma insulin level. The change in body weight 
was observed throughout treatment period in the 
experimental animals. At the end of 30 days, the 
animals were sacrificed by cervical decapitation 
for serum biochemical parameters examination 
(hemoglobin, glycosylated Hb, total protein, 
serum creatinine, serum urea). Blood was 
collected from the heart in two different tubes, i.e. 
one with anticoagulant for plasma, and another 
with anticoagulant for serum separation. Serum 
was separated by centrifugation 3500 rpm at 25 
oC for 10 min. Fasting blood glucose was 
estimated by O-toluidine method [14]. Plasma 
insulin level was assayed by the radio-
immunoassay method. All biochemical tests were 
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carried out using commercial kits obtained from 
Erba diagnostic Mannheim Gmbh, Germany. 
 
Oral glucose tolerance test 
 
The rats were divided into four groups of 10 
animals each. Group I served as control and 
received distilled water. Group II served as 
diabetic control and received distilled water. 
Group III served as positive control, received 
glibenclamide (1 mg/kg b.w.). Group IV received 
SNE 100 gm/kg orally. The rats were fasted for 
18 h and the test performed following oral 
administration of glucose (2 g/kg) to diabetic and 
normal rats 30 min after dosing. Blood samples 
were collected from the retro-orbital (under light 
ether anesthesia) immediately (0 h), 30, 60, 90, 
and 120 min after the glucose administration and 




Data are presented as mean ± standard 
deviation (SD), and were analyzed by one-way 
ANOVA followed by Tukey’s multiple comparison 
using SPSS 17.0 software for Windows. 
Differences were considered statistically 




Effect of SNE on blood glucose and plasma 
insulin  
 
Fasting blood glucose levels in the negative 
group remained unchanged during the course of 
the experiment. Compared to normal group, level 
of fasting blood glucose was significantly (p < 
0.01) higher and the plasma insulin level was 
significantly decreased in diabetic groups (p < 
0.01). On the other hand, administration of SNE 
for 30 days was found to lower the blood glucose 
and increase the insulin level significantly (p < 
0.01) in a dose dependent manner when 
compared with control groups (Tables 1 and 2). 
 
Effect of SNE on biochemical parameters 
 
STZ induced significant (p < 0.05) elevations in 
serum creatinine and urea levels and decrease in 
total protein when compared to normal group. 
 
However, treatment with different doses of SNE 
significantly (p < 0.05) reduced serum creatinine 
and serum urea level and increased total protein 
when compared to those of diabetic control 
groups (Table 3). 
        Table 1: Effect of SNE on blood glucose level in rats (mean ± SD, n = 10) 
 
Group Dose (mg/kg)  Blood glucose (mg/dL)  
  Initial Day 15 Day 30 
Negative  — 61.34 ± 2.46 92.18 ± 3.26** 79.15 ± 2.76** 
Model — 276.22 ± 2.23 334.51 ± 3.38 324.13 ± 4.22 
GLI 1 282.45 ± 2.17 169.26 ± 3.17** 114.33 ± 2.75** 
SNE-L 50 276.34 ± 3.25 254.29 ± 3.45* 223.08 ± 3.54* 
SNE-M 100 289.15 ± 2.43 229.14 ± 4.26** 159.25± 3.26** 
SNE-H 200 267.24 ± 2.32 227.46 ± 3.23** 120.21 ± 3.37** 
Key: *P < 0.05，**p < 0.01 vs. control group. GLI: glibenclamide; SNE-L: low dose of SNE; SNE-M: 
middle dose of SNE; SNE-H: high dose of SNE 
 
      Table 2: Effect of SNE on plasma insulin level in rats (mean ± SD, n=10) 
 
Group Dose (mg/kg)  Plasma insulin (uU/mL) 
  Initial Day15 Day 30 
Negative  — 22.38 ± 0.74 17.68 ± 0.81** 18.27 ± 0.51** 
Model — 6.51 ± 0.48 5.26 ± 0.54 2.46 ± 0.49 
GLI 1 5.25 ± 0.49 13.36 ± 0.74** 12.53 ± 0.59** 
SNE-L 50 6.42 ± 0.52 6.28 ± 0.68* 8.24 ± 0.73* 
SNE-M 100 5.84 ± 0.54 11.24 ± 0.84** 12.18 ± 0.72** 
SNE-H 200 6.27 ± 0.46 10.73 ± 0.76** 13.31 ± 0.67** 
Key: *P < 0.05，**p < 0.01 vs. control group. GLI: glibenclamide; SNE-L: low dose of SNE; SNE-M: middle dose 
of SNE; SNE-H: high dose of SNE 
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Table 3: Effect of SNE on biochemical parameters in rats (mean ± SD, n = 10) 
 
Group Dose Hemoglobin Glycosylated Hb  Serum creatinine Serum urea  Total proteins 
 (mg/kg) (mg/dL)  (Hb%)  (mg/dL) (mg/dL) (g/dL) 
Negative  — 13.41±2.25* 6.76 ±0.75* 0.89 ±0.18* 31.23±1.76* 8.35 ±1.41* 
Model — 8.28±1.54 17.56 ±1.14 2.62 ±0.25 83.45±2.21 4.18 ±1.26 
GLI 1 10.53±2.34 13.39 ±0.79 0.94 ±0.22* 35.53±1.37* 7.47 ±1.39* 
SNE-L 50 9.78±1.34* 14.25 ±0.77* 1.68 ±0.18* 76.18±2.25* 6.52 ±1.27* 
SNE-M 100 10.69±1.56* 10.26 ±0.71* 1.23 ±0.17* 57.38±1.76* 6.84 ±1.16* 
SNE-H 200 11.78±1.76* 8.26 ±0.75* 0.86 ±0.24* 41.86±1.59* 7.89 ±1.25* 
Key:*P < 0.05，**p < 0.01 vs. control group. GLI: glibenclamide; SNE-L: low dose of SNE; SNE-M: middle dose of 
SNE; SNE-H: high dose of SNE 
 
Table 4: Effect of SNE on fasting blood glucose level in rats (mean ± SD, n = 10) 
 
Group Dose Fasting blood glucose level (mg/dL) 
 (mg/kg) 0 h 0.5 h 1 h 1.5 h 2 h 
Negative — 93.5 ± 0.6 112.3 ± 1.2 122.6 ± 1.1 134.8 ± 1.3 138.7 ± 1.5 
Model — 241.2 ± 1.2 265.1 ± 0.9 284.3 ± 1.3 282.5 ± 1.1 308.2 ± 1.3 
GLI 1 256.7 ± 1.1 263.4 ± 1.4* 267.4 ± 1.4* 276.5 ± 1.2* 264.5 ± 1.2* 
SNE-H 200 255.2 ± 1.4 257.3 ± 1.2* 265.7 ± 1.2* 284.6 ± 1.2* 267.2 ± 1.3* 
Key:*P < 0.05，**p < 0.01 vs. control group. GLI: glibenclamide; SNE-H: high dose of SNE 
 
Effect of SNE on oral glucose tolerance test 
(OGTT) 
 
The results indicated that the SNE (200 mg/kg) 
and glibenclamide (1 mg/kg) reduced blood 
glucose level significantly (p < 0.05) after 120 
min of oral administration, when compared to 




Diabetes is a metabolic disorder of carbohydrate, 
fat and protein, affecting a large number of 
population in the world [1]. Diabetes mellitus is 
not a single disorder 
but it is a group of metabolic disorder 
characterized by chronic hyperglycemia, 
resulting from defects in insulin secretion, insulin 
action, or both. Increased thirst, increased 
urinary output, ketonemia and ketonuria are the 
common symptoms of diabetes mellitus, which 
occur due to the abnormalities in carbohydrate, 
fat, and protein metabolism. Chinese medicinal 
herb have been shown to exert hypoglycemic 
activities through stimulation of insulin release 
[15]. It is assumed that Scrophularia ningpoensis 
extract could be responsible for stimulation of 
insulin and the restoration of metabolic activity. 
 
Diabetic hyperglycemia induces elevation of 
serum level of urea and creatinine, which were 
considered as significant markers of renal 
dysfunction [16]. Increase in serum level of urea 
and creatinine levels in STZ-diabetic rats may 
indicate diminished ability of the kidney to filter 
these waste products from the blood and excrete 
them in the urine. The results indicate that 
treatment of diabetic group with Scrophularia 
ningpoensis extract significantly reduced serum 
urea and creatinine level. Based on these 
findings, SNE may enhance the ability of the 
kidney to remove these waste products from the 
blood in diabetic rats. 
 
Catalase has been shown to be responsible for 
the detoxification of H2O2, and protect the tissues 
from highly reactive hydroxyl radicals [19]. The 
decrease in CAT activity could have resulted 
from in activation by glycation of enzyme [20]. In 
the present study, extract-treated groups showed 
a significant increase in the hepatic and renal 
SOD and CAT activities of the diabetic rats. This 
means that the extracts can reduce the potential 
glycation of enzymes or they may reduce 
reactive oxygen free radicals and improve the 
activities of antioxidant enzymes. This result 
clearly shows that Scrophularia ningpoensis 
contains free radical scavenging activity, which 
could exert a beneficial action against 
pathological alteration caused by the presence of 





The findings of the study indicate that SNE 
exerts pronounced antidiabetic activity in rats. 
Thus, it has a potential for clinical application for 
the treatment of diabetes. Therefore, further 
studies are required to develop the extract for 
use in humans. 
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